Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 5/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | LIPE | Q05469 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10321994 | 1.00 | ADRB2 (0.36) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL18228941 | 1.00 | ADRB2 (0.36) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL18228940 | 1.00 | ADRB2 (0.36) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL18228936 | 0.96 | MAPT (0.35) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL8219271 | 0.96 | MAPT (0.35) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL18228935 | 0.96 | MAPT (0.35) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL8222724 | 0.96 | MAPT (0.35) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL692443 | 0.83 | ADRB2 (0.33) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL31412820 | 0.83 | ADRB2 (0.33) | ADRB2ADRB1ADRB3ALDH1A1MAPT | |
| SCHEMBL8223325 | 0.83 | ADRB2 (0.33) | ADRB2ADRB1ADRB3ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130065969-A9 | Odour Compounds | GIVAUDAN SA (CH) | 2013-03-14 | — | — | US | disclosed |
| US-20130065969-A9 | Odour Compounds | GIVAUDAN SA (CH) | 2013-03-14 | — | — | US | disclosed |
| US-20130065969-A9 | Odour Compounds | GIVAUDAN SA (CH) | 2013-03-14 | — | — | US | disclosed |
| US-20120184630-A1 | Odour Compounds | KRAFT PHILIP (CH) | 2012-07-19 | — | — | US | disclosed |
| US-20120184630-A1 | Odour Compounds | KRAFT PHILIP (CH) | 2012-07-19 | — | — | US | disclosed |
| US-20120184630-A1 | Odour Compounds | KRAFT PHILIP (CH) | 2012-07-19 | — | — | US | disclosed |
| EP-2475639-A2 | ODOUR COMPOUNDS | Givaudan SA (CH) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011029895-A2 | ODOUR COMPOUNDS | GIVAUDAN SA (CH) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011029895-A2 | ODOUR COMPOUNDS | GIVAUDAN SA (CH) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065969-A9 | Odour Compounds | PRMT9, PRMT5, PRMT1 | ADRB2 543/4885ADRB1 527/4885ADRB3 945/4885 |
| US-20120184630-A1 | Odour Compounds | PRMT9, PRMT5, PRMT1 | ADRB2 543/4885ADRB1 527/4885ADRB3 945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.